X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Wilson Daniel G. | CFO | S - Sale | $135.42 | -5,188 | 30,794 | -14% | -$702,553 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Turakhia Minang | CHIEF MED, SCI OFCR EVP ADVTEC | S - Sale | $135.42 | -7,804 | 48,899 | -14% | -$1,056,809 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $135.42 | -4,041 | 20,275 | -17% | -$547,228 | ||||||
| M | 2026-02-24 | OFIX | Orthofix Medical Inc. | Engine Capital Management, LP | 10% | P - Purchase | $12.59 | +137,858 | 4,390,779 | +3% | +$1,734,956 | |||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $135.42 | -6,217 | 39,182 | -14% | -$841,899 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $135.42 | -4,797 | 15,014 | -24% | -$649,604 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Patterson Chad | CHIEF COMM, PRODUCT OFFICER | S - Sale | $135.42 | -8,967 | 51,738 | -15% | -$1,214,301 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Murphy Patrick Michael | CBO, CLO | S - Sale | $135.42 | -7,805 | 60,536 | -11% | -$1,056,945 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $135.42 | -25,540 | 186,126 | -12% | -$3,458,599 | ||||||
2026-02-24 | TCMD | Tactile Systems Technology Inc | Dodd Sheri Louise | CEO | S - Sale | $28.94 | -10,993 | 243,885 | -4% | -$318,144 | ||||||
2026-02-24 | TCMD | Tactile Systems Technology Inc | Birkemeyer Elaine M. | CFO | S - Sale | $28.94 | -7,701 | 134,819 | -5% | -$222,880 | ||||||
2026-02-24 | TCMD | Tactile Systems Technology Inc | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.94 | -6,246 | 82,581 | -7% | -$180,764 | ||||||
2026-02-25 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale | $15.17 | -19,951 | 205,730 | -9% | -$302,657 | ||||||
2026-02-24 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.81 | +2,000 | 142,113 | +1% | +$7,620 | ||||||
2026-02-25 | PODD | Insulet Corp | Minogue Michael R | Dir | P - Purchase | $246.23 | +2,030 | 18,261 | +13% | +$499,847 | ||||||
2026-02-24 | IRTC | Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $140.91 | -280 | 10,601 | -3% | -$39,455 | ||||||
2026-02-24 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $140.91 | -732 | 15,106 | -5% | -$103,146 | ||||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $36.97 | -2,561 | 133,155 | -2% | -$94,690 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $36.94 | -3,682 | 41,921 | -8% | -$136,013 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $36.92 | -4,747 | 172,288 | -3% | -$175,269 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $36.83 | -34,898 | 863,125 | -4% | -$1,285,337 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Berry Lance A | EVP, COO, CFO, Treasurer | S - Sale | $36.69 | -9,466 | 181,447 | -5% | -$347,309 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $36.92 | -5,848 | 209,306 | -3% | -$215,882 | |||||
2026-02-23 | SINT | Sintx Technologies, Inc. | Moyes Jay M | Dir | P - Purchase | $2.91 | +1,000 | 4,000 | +33% | +$2,910 | ||||||
2026-02-23 | TCMD | Tactile Systems Technology Inc | Birkemeyer Elaine M. | CFO | S - Sale | $28.30 | -5,518 | 142,520 | -4% | -$156,144 | ||||||
2026-02-23 | TCMD | Tactile Systems Technology Inc | Dodd Sheri Louise | CEO | S - Sale | $28.30 | -15,240 | 254,878 | -6% | -$431,245 | ||||||
2026-02-23 | TCMD | Tactile Systems Technology Inc | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.30 | -4,439 | 88,827 | -5% | -$125,612 | ||||||
| D | 2026-02-23 | IRTC | Irhythm Holdings, Inc. | Talwalkar Abhijit Y | Dir | S - Sale+OE | $145.70 | -5,312 | 20,299 | -21% | -$773,980 | |||||
| D | 2026-02-18 | PLSE | Pulse Biosciences, Inc. | Danahy Kevin Patrick | Chief Commercial Officer | S - Sale+OE | $23.64 | -5,000 | 43,298 | -10% | -$118,200 | |||||
| D | 2026-02-19 | GKOS | Glaukos Corp | Weisner Aimee S | Dir | S - Sale+OE | $117.38 | -15,000 | 48,311 | -24% | -$1,760,761 | |||||
2026-02-19 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.15 | +3,000 | 140,127 | +2% | +$12,450 | ||||||
2026-02-20 | ARAY | Accuray Inc | Mayer Steven F | Dir | P - Purchase | $0.56 | +54,875 | 1,545,620 | +4% | +$30,878 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Patience David | CFO | P - Purchase | $4.10 | +3,657 | 268,657 | +1% | +$14,994 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Gordon Gary B. | Dir | P - Purchase | $4.10 | +9,756 | 9,756 | New | +$40,000 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Valle William | Dir | P - Purchase | $4.10 | +30,487 | 30,487 | New | +$124,997 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $4.10 | +30,487 | 773,289 | +4% | +$124,997 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Stansky Michael P | Dir | P - Purchase | $4.10 | +361,098 | 986,830 | +58% | +$1,480,502 | ||||||
| A | 2025-12-09 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.81 | +2,710 | 391,628 | +1% | +$4,905 | |||||
2026-02-20 | PODD | Insulet Corp | McEvoy Ashley | Pres, CEO | P - Purchase | $239.35 | +4,300 | 13,920 | +45% | +$1,029,205 | ||||||
2026-02-20 | CVRX | Cvrx, Inc. | Jain Mudit K. | Dir | P - Purchase | $6.36 | +46,800 | 985,833 | +5% | +$297,592 | ||||||
| M | 2026-02-18 | ARAY | Accuray Inc | Mayer Steven F | Dir | P - Purchase | $0.53 | +195,125 | 1,490,745 | +15% | +$103,797 | |||||
2026-02-17 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $25.60 | -15,000 | 379,786 | -4% | -$384,020 | ||||||
2026-02-18 | SINT | Sintx Technologies, Inc. | Anderson Mark Lewis | Dir | P - Purchase | $3.02 | +3,000 | 18,000 | +20% | +$9,060 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Recupero Anthony J | See Remarks | S - Sale | $15.40 | -21,049 | 243,418 | -8% | -$324,204 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $15.35 | -20,756 | 285,974 | -7% | -$318,642 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $15.32 | -93,475 | 895,688 | -9% | -$1,432,122 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.37 | -21,528 | 266,466 | -7% | -$330,982 | ||||||
2026-02-12 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.65 | -33,847 | 1,533,165 | -2% | -$55,848 | ||||||
2026-02-12 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.65 | -14,120 | 673,561 | -2% | -$23,298 | ||||||
2026-02-18 | CVRX | Cvrx, Inc. | Jain Mudit K. | Dir | P - Purchase | $4.64 | +600 | 939,033 | 0% | +$2,785 | ||||||
2026-02-18 | BDX | Becton Dickinson & Co | Scott Bertram L | Dir | S - Sale | $182.61 | -953 | 36,763 | -3% | -$174,027 | ||||||
| DM | 2026-02-12 | PLSE | Pulse Biosciences, Inc. | Danahy Kevin Patrick | Chief Commercial Officer | S - Sale+OE | $23.51 | -60,000 | 43,298 | -58% | -$1,410,600 | |||||
| D | 2026-02-12 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $24.49 | -65,153 | 221,574 | -23% | -$1,595,486 | |||||
| D | 2026-02-12 | GMED | Globus Medical Inc | Huller Kelly | EVP, GC, Corporate Secretary | S - Sale+OE | $87.67 | -10,000 | 0 | -100% | -$876,700 | |||||
2026-02-12 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $68.01 | -1,012 | 26,019 | -4% | -$68,826 | ||||||
| DM | 2026-01-09 | STSS | Sharps Technology Inc. | Falconx Holdings Ltd | 10% | S - Sale+OE | $1.94 | -769,320 | 461,538 | -63% | -$1,490,755 | |||||
2026-02-13 | IRMD | Iradimed Corp | Allen Monty K | Dir | S - Sale | $100.26 | -1,000 | 21,000 | -5% | -$100,256 | ||||||
| D | 2026-02-11 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale+OE | $172.75 | -5,145 | 3,150 | -62% | -$888,796 | |||||
2026-02-10 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.55 | -3,485 | 687,681 | -1% | -$5,402 | ||||||
2026-02-10 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.55 | -40,976 | 1,567,012 | -3% | -$63,513 | ||||||
| DM | 2026-02-09 | PLSE | Pulse Biosciences, Inc. | Danahy Kevin Patrick | Chief Commercial Officer | S - Sale+OE | $23.39 | -60,000 | 43,298 | -58% | -$1,403,400 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $16.00 | +3,690,000 | 2,054,678 | -226% | +$59,040,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Behbahani Ali | Dir, 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Baskett Forest | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | New Enterprise Associates 17, L.P. | 10% | P - Purchase | $16.00 | +937,500 | 6,035,038 | +18% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Yang Rick | 10% | P - Purchase | $16.00 | +937,500 | 6,035,038 | +18% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Sandell Scott D | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Chang Carmen | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Walker Paul Edward | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Mathers Edward T | 10% | P - Purchase | $16.00 | +937,500 | 6,035,038 | +18% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Pardo Geoffrey B | Dir | P - Purchase | $16.00 | +312,500 | 2,187,513 | +17% | +$5,000,000 | |||||
2026-02-09 | SGP | Spyglass Pharma, Inc. | Khan Bilal Arshad | Dir | P - Purchase | $16.00 | +135,000 | 276,877 | +95% | +$2,160,000 | ||||||
| D | 2026-02-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale+OE | $27.46 | -22,562 | 591,656 | -4% | -$619,553 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Nielsen Kirk G. | Dir | P - Purchase | $16.00 | +165,000 | 3,310,619 | +5% | +$2,640,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Vensana Capital I Gp, LLC | 10% | P - Purchase | $16.00 | +165,000 | 3,310,619 | +5% | +$2,640,000 | |||||
| AD | 2026-02-09 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $169.97 | -20,519 | 21,422 | -49% | -$3,487,614 | |||||
| D | 2026-02-09 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $170.34 | -25,055 | 21,422 | -54% | -$4,267,869 | |||||
2026-02-09 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale | $169.97 | -20,519 | 21,422 | -49% | -$3,487,614 | ||||||
| D | 2026-02-09 | MMM | 3M Co | Chavez Rodriguez Beatriz Karina | Group Pres | S - Sale+OE | $171.13 | -1,190 | 19,859 | -6% | -$203,645 | |||||
| D | 2026-02-09 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $273.78 | -4,991 | 468,313 | -1% | -$1,366,436 | |||||
2026-02-05 | HTFL | Heartflow, Inc. | Cullivan Julie A | Dir | S - Sale | $27.32 | -8,000 | 36,413 | -18% | -$218,560 | ||||||
2026-02-05 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $13.79 | -60,425 | 349,500 | -15% | -$833,261 | ||||||
| M | 2026-02-04 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $363.44 | -500,000 | 15,824,296 | -3% | -$181,719,269 | |||||
2026-02-04 | HTFL | Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC | 10% | S - Sale | $28.05 | -2,000,000 | 10,448,158 | -16% | -$56,100,000 | ||||||
2026-02-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $251.31 | -2,000 | 64,773 | -3% | -$502,620 | ||||||
2026-02-04 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $260.00 | -50 | 9,691 | -1% | -$13,000 | ||||||
2026-02-03 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $14.71 | -37,358 | 1,173,025 | -3% | -$549,536 | ||||||
2026-02-02 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $16.42 | -337 | 90,085 | 0% | -$5,532 | ||||||
| D | 2026-02-02 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $93.49 | -160,901 | 1,625,414 | -9% | -$15,043,394 | |||||
| D | 2026-02-02 | SYK | Stryker Corp | Pierce James Andrew | Group Pres | S - Sale+OE | $368.87 | -475 | 73,583 | -1% | -$175,215 | |||||
2026-02-02 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $257.03 | -1,000 | 85,495 | -1% | -$257,030 | ||||||
| M | 2026-01-15 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $1.62 | -61,194 | 1,139,177 | -5% | -$99,331 | |||||
2026-01-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, CRO, Pres Life Sciences | S - Sale | $202.73 | -75 | 16,431 | 0% | -$15,205 | ||||||
2026-01-26 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $100.65 | -5,000 | 4,487,950 | 0% | -$503,255 | ||||||
2026-01-26 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale | $15.57 | -2,943 | 225,681 | -1% | -$45,823 | ||||||
| D | 2026-01-22 | GKOS | Glaukos Corp | Stapley Marc | Dir | S - Sale+OE | $127.71 | -15,000 | 37,449 | -29% | -$1,915,576 | |||||
| D | 2026-01-22 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $127.68 | -10,498 | 92,366 | -10% | -$1,340,380 | |||||
| D | 2026-01-21 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $124.65 | -4,502 | 92,366 | -5% | -$561,174 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |